Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Directly managed European call · HORIZON-MISS-2027-02-CANCER-03
The title is in English, the language of the official source.
A consortium is required.
The general EU rules ask for at least three independent legal entities from three Member States or associated countries. An SME cannot apply on its own.
- ProgrammeHorizon Europe
- Deadlinecloses in 305 days
- Opening10/02/2027
- Next cut-off16/09/2027
- All cut-offs16/09/2027
- Official type of actionResearch and Innovation Action (RIA)
Framework call: Supporting the implementation of the Cancer Mission · HORIZON-MISS-2027-02
Topics: Anticancer therapy, Biophotonics, Imaging, image and data processing, Cancer and its biological basis, Quality-of-life, Radiation therapy, Surgery, Tomography
See the call on the European Commission portal
Partners for the consortium
Organisations from other countries that have already taken part in 3 Horizon Europe projects, chosen by the same topic in other years. Those from Spain are not shown.
| Organisation | Country | Type | Projects | An example project |
|---|---|---|---|---|
| EUROPEAN CANCER ORGANISATION | Belgium | Other entity | 2 | IMPACT (2026) |
| RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG | Germany | University | 2 | IMPACT (2026) |
| ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA | Italy | University | 1 | LiT-Met (2026) |
| STICHTING AMSTERDAM UMC | Netherlands | Research centre | 1 | PALACROS (2026) |
| UNIVERSITEIT GENT | Belgium | University | 1 | IMPACT (2026) |
| ALESI SURGICAL LIMITED | United Kingdom | Company · SME | 1 | IMPACT (2026) |
| ASSISTANCE PUBLIQUE HOPITAUX DE PARIS | France | Research centre | 1 | LiT-Met (2026) |
| AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO | Italy | Public administration | 1 | LiT-Met (2026) |
| BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) | Austria | Research centre | 1 | PALACROS (2026) |
| BIOLT SRLS | Italy | Company · SME | 1 | LiT-Met (2026) |
| CAPNOPHARM GMBH | Germany | Company · SME | 1 | IMPACT (2026) |
| CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE | Belgium | Research centre | 1 | LiT-Met (2026) |
Countries with the most organisations: Italy (10), Austria (6), Belgium (6), Germany (5), Denmark (4), Netherlands (4), United Kingdom (3), France (2).
That an organisation has taken part before does not mean it is looking for partners now: it is a starting point for finding whom to approach. Each applicant decides its consortium.
Origen de los datos: CORDIS, Comisión Europea.
Other calls under Horizon Europe
Short proposal
Next-Generation QKD Systems
Neutral-Atom Platform Technologies
Trapped-Ion Platform Technologies
All calls under Horizon Europe
We classify each call by its official type of action and the general EU rules: collaborative research and innovation actions ask, as a rule, for three entities from three countries; many coordination and support actions and prizes accept a single entity; the EIC Accelerator is for a single company. Whatever the programme regulation does not set stays under “it depends”. The official text of each call prevails.
Origen de los datos: portal Funding & Tenders de la Comisión Europea (datos abiertos).